P. Breitenberger

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

W. Lehmacher, W. Maerz, U. Julius, 2013, Circulation.

Progressive Cardiovascular Disease : Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy

W. Lehmacher, W. Maerz, U. Julius, 2013 .

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular DiseaseHighlights

F. Kronenberg, W. Lehmacher, B. Nordestgaard, 2016 .

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.

F. Kronenberg, W. Lehmacher, B. Nordestgaard, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.

F. Kronenberg, W. Lehmacher, B. Nordestgaard, 2016, Arteriosclerosis, thrombosis, and vascular biology.